Tag: equity
-
Biotechs Apply Crispr Gene-Editing for Hemophilia
A treatment for the blood disease hemophilia and other inherited disorders are being developed with the gene-editing technology Crispr in a biotechnology deal.
-
Drug Maker Licenses Low-Dose Vaccine Patch
The pharmaceutical company Merck is licensing a microneedle patch device that delivers vaccines with a small fraction of the dose normally needed by syringes.
-
Antibody Drug Biotech Raises $105M in Venture Funds
A company that says it has a faster process for discovering therapeutic antibodies is raising $105 million in its second venture finance round.
-
Merck Inks Three Covid-19 Vaccine, Therapy Deals
Drug maker Merck today gained a new acquisition, along with collaboration and licensing deals, for vaccines and a therapy for Covid-19 infections.
-
Psychiatric Drug Maker Raises $80M in Venture Funds
A developer of treatments for mental health disorders based on controlled hallucinogenic substances is raising $80 million in new venture financing.
-
Infographic – Biotech Remains Hottest Venture Sector
A report on venture capital investments for the first quarter of 2020 shows biotechnology companies remain the largest recipients of venture investor dollars.
-
Venture Deals Decline in Q1, Biotech Sizzles Again
The number of venture deals declined for the third straight quarter as 2020 opened, but biotechnology remained the hottest single sector for investors.
-
Infographic – Biotech Index Dives, Rebounds
We check in from time to time on the Nasdaq Biotechnology Index as an indicator of the overall health of research-based businesses in the U.S.
-
Venture-Backed Start-Ups to Get Small Biz Loans
An industry group says rules for loans to small companies hard-hit by Covid-19 are changed to allow these loans for more start-ups funded by venture capital.
-
Life Science Venture Funds Raise $2.56B for Start-Ups
Two investment companies specializing in health care and life sciences revealed new venture funds to finance young enterprises with innovative technologies.